Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Repositionable Aortic Endograft Limb Twisting and Thrombosis.

Journal of vascular surgery·2026
Same journal

Patient Reported Long-Term Quality of Life and Symptom Resolution after First Rib Resection and Anterior Scalenectomy.

Journal of vascular surgery·2026
Same journal

Frailty is associated with fewer hospital-free days following peripheral artery disease revascularization.

Journal of vascular surgery·2026
Same journal

Shifting Burden of Major Lower Extremity Amputations Across Hospital Medicaid Burden and Socioeconomic Groups, 1993-2021.

Journal of vascular surgery·2026
Same journal

The United Kingdom Branch Endoprosthesis for Aortic arch Treatment study (UK-BEAT): Early experience with the GORE TAG thoracic branch endoprosthesis.

Journal of vascular surgery·2026
Same journal

Association of revascularization strategy with wound healing following toe amputation in chronic limb-threatening ischemia.

Journal of vascular surgery·2026

Related Experiment Video

Updated: Jun 25, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

Leg ulcer treatment.

Philip D Coleridge-Smith1

  • 1British Vein Institute, London, United Kingdom. p.coleridgesmith@ucl.ac.uk

Journal of Vascular Surgery
|March 10, 2009
PubMed
Summary
This summary is machine-generated.

Compression therapy, including bandages or stockings, is effective for healing venous ulcers and preventing recurrence. Superficial venous surgery also helps prevent recurrence after healing, while minimally invasive procedures show promise for treating venous leg ulcers.

Related Experiment Videos

Last Updated: Jun 25, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

Area of Science:

  • Vascular Surgery
  • Dermatology
  • Wound Care

Background:

  • Venous ulcers present significant challenges for patients and healthcare systems due to pain and high treatment costs.
  • Effective management strategies are crucial for improving patient outcomes and reducing healthcare burdens.

Purpose of the Study:

  • To review and highlight effective management methods for venous ulcers.
  • To provide evidence-based recommendations for treating and preventing venous leg ulcers.

Main Methods:

  • Review of level 1 evidence regarding compression therapy efficacy.
  • Analysis of the role of superficial venous surgery, including minimally invasive techniques (endovenous laser ablation, radiofrequency ablation, foam sclerotherapy).
  • Evaluation of adjunctive treatments like perforating vein ligation, deep vein reconstruction, and pharmacological agents.

Main Results:

  • Compression therapy (bandaging or stockings) has level 1 evidence for healing and maintaining healing of venous ulcers.
  • Superficial venous surgery effectively prevents recurrence after ulcer healing but does not accelerate initial healing.
  • Minimally invasive procedures for superficial venous incompetence are likely effective for venous leg ulcer treatment; data on perforating vein ligation and deep vein reconstruction are insufficient for recommendations.
  • Limited drugs show efficacy in promoting healing, particularly for refractory ulcers, when used with compression. No specific ulcer dressing has demonstrated accelerated healing.

Conclusions:

  • Compression therapy is the cornerstone of venous ulcer management and recurrence prevention.
  • Superficial venous surgery and minimally invasive techniques are valuable adjuncts for preventing recurrence in specific patient groups.
  • Further research is needed to define the roles of perforating vein ligation and deep vein reconstruction. Pharmacological agents and appropriate dressings should be considered for refractory cases.